Overall, our results indicate that the selective removal of superoxide anions could represent a new and more effective approach to cope with the enhanced oxidative conditions associated with PD, and support the further exploration of exogenous SOD-related molecules as a therapeutic strategy against PD. The gene discussed is SOD1; the disease is Parkinson disease.